{
  "figure_1": "A The Circos plot shows the differentially expressed circRNAs in exosomes derived from CAFs and NFs. The outermost circle shows the chromosomal distribution of the circRNAs. The second circle indicates the circBase ID of the predominantly enriched circRNAs in exosomes derived from CAFs (orange) or NFs (blue). The third circle shows the log2FC of differentially expressed circRNAs (orange squares for upregulated circRNAs and purple squares for downregulated circRNAs). The fourth circle shows the number of reads the differentially expressed circRNAs matched after normalization (orange circles for CAFs and blue triangles for NFs). B The qRT-PCR analysis showing the circTBPL1 expression in exosomes secreted by NFs and CAFs (left) and that in the corresponding NFs and CAFs (right). C ISH assay was performed to detect the localization of circTBPL1 in breast cancer tissue, and HE staining was used to show the histology. D Schematic illustration showing the genomic location and splicing pattern of circTBPL1. The back-splice junction (red triangle) of circTBPL1was confirmed by sanger sequencing. E cDNA and gDNA of CAFs were amplified using convergent and divergent primers. β-actin was used as the negative control. F The qRT–PCR analysis was used to detect the expression of circTBPL1 and linear TBPL1 in CAFs treated with actinomycin D for indicated time. G The qRT–PCR analysis was performed to evaluate the expression of circTBPL1 and linear TBPL1 in CAFs treated with RNase R. H The expression of circTBPL1 and linear TBPL1 were evaluated by qRT-PCR using random primers or oligo dT primers. I The expression of circTBPL1 in the cytoplasm and nucleus of CAFs was evaluated by qRT–PCR. GAPDH and U6 were used as cytoplasmic and nuclear RNA markers, respectively. J FISH assay was used to detect the subcellular localization of circTBPL1 in CAFs. (ns, no significance, *P < 0.05, **P < 0.01).",
  "figure_3": "A The circTBPL1 overexpression efficiency and TBPL1 expression level were verified using qRT-PCR assay. B–D The proliferation of breast cancer cells after circTBPL1 overexpression was detected by MTT assay (B), colony formation assay (C), and Edu assay (D). E Transwell assay was performed to evaluate the effect of circTBPL1 overexpression on the migration and invasion abilities of breast cancer cells. F Wound healing assay was used to detect the cell migration after circTBPL1 overexpression in breast cancer cells. G Phalloidin staining was used to show the morphological change of breast cancer cells transfected with pLCDH-ciR or circTBPL1. H The expression of EMT-related markers was assessed by western blot. I Tube formation assay was performed to evaluate the angiogenesis-promoting effect of circTBPL1 overexpression in breast cancer cells. (ns, no significance, *P < 0.05, **P < 0.01, ***P < 0.001).",
  "figure_4": "A The expression of circTBPL1 in the cytoplasm and nucleus of breast cancer cells was evaluated by qRT–PCR. GAPDH and U6 were used as cytoplasmic and nuclear RNA markers, respectively. B FISH assay was used to detect the subcellular localization of circTBPL1 in breast cancer cells. C Venn diagram showing the potential circTBPL1-binding miRNAs, predicted by CircInteractome and Starbase databases. D The schematic diagram of luciferase reporter (top). The predicted circTBPL1-binding site with miR-653-5p and the corresponding mutant sequence (bottom). E The binding relationship between circTBPL1 and miR-653-5p was verified using the dual-luciferase reporter assay. F RIP assay detected the enrichment of circTBPL1 and miR-653-5p in breast cancer cells. G RNA-FISH showed that circTBPL1 was colocalized with miR-653-5p in breast cancer cells. H The miR-653-5p expression after circTBPL1 knockdown in breast cancer cells. (ns, no significance, *P < 0.05, **P < 0.01, ***P < 0.001).",
  "figure_6": "A Venn diagram showing the potential downstream target genes of miR-653-5p, predicted by DIANA, miRDB, mirDIP, and Starbase databases (top). The predicted miR-653-5p-binding sites with TPBG and the corresponding mutant sequence (bottom). B, C The mRNA and protein levels of TPBG after circTBPL1 overexpression (B) or circTBPL1 knockdown (C) were detected. D The mRNA and protein levels of TPBG after miR-653-5p overexpression were evaluated. E Following circTBPL1 overexpression and miR-653-5p mimics transfection, the mRNA and protein expression of TPBG was measured. F The binding relationship between miR-653-5p and TPBG was verified using the dual-luciferase reporter assay. G The overexpression efficiency of TPBG was evaluated using qRT-PCR and western blot. H–J Cellular proliferation following TPBG overexpression was assessed via MTT assay (H), colony formation assay (I), and Edu assay (J). K Wound healing assay was employed to appraise cell migration. L Transwell assay was implemented to analyze cell migration and invasion. M The expression of EMT-related markers in these cells was examined via western blot. (ns, no significance, *P < 0.05, **P < 0.01, ***P < 0.001).",
  "figure_8": "A Nude mice were subcutaneously implanted with MDA-MB-231 cells co-injected with CAF pLCDH-ciR or CAF circTBPL1. The images of xenograft tumors in each group. B, C Tumor volume (B) and weight (C) were measured in each group. D, E qRT-PCR (D) and western blot (E) were used to detect the expression of related factors in tumor tissues. F Tumor tissues from xenograft model mice were subjected to HE staining, and IHC staining was performed to evaluate the expression of the related factors in tumor tissues. G Representative images of the lung tissues after tail vein injection of MDA-MB-231 cells with or without circTBPL1 overexpression. H Representative images of HE staining for lung tissues in each group. I The histogram analysis of the metastatic nodules number in per lung. J The schematic overview illustrates the mechanistic basis for the observational study results. CAF-derived circTBPL1 is transmitted into breast cancer cells through exosomes and can therein modulate the miR-653-5p/TPBG axis to influence tumor growth and metastasis. (**P < 0.01, ***P < 0.001)."
}